These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 8884161)

  • 1. A comparative review of the adverse effects of calcium antagonists.
    Dougall HT; McLay J
    Drug Saf; 1996 Aug; 15(2):91-106. PubMed ID: 8884161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade.
    Noll G; Lüscher TF
    Cardiology; 1998; 89 Suppl 1():10-5. PubMed ID: 9570424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction.
    Gillman MW; Ross-Degnan D; McLaughlin TJ; Gao X; Spiegelman D; Hertzmark E; Goldman L; Soumerai SB
    J Am Geriatr Soc; 1999 May; 47(5):512-7. PubMed ID: 10323641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-channel blockers in ischemic heart disease.
    Silvestry FE; Kimmel SE
    Curr Opin Cardiol; 1996 Jul; 11(4):434-9. PubMed ID: 8879955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of calcium channel blockers in hypertension.
    Conlin PR; Williams GH
    Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydropyridine calcium antagonists and the trough: peak ratio: focus on adverse effects.
    Myers MG
    J Hypertens Suppl; 1994 Nov; 12(8):S73-6; discussion S76-7. PubMed ID: 7707160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium antagonists--assessment of side effects.
    Thulin T
    Scand J Prim Health Care Suppl; 1990; 1():81-4. PubMed ID: 2100370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of calcium-channel blockers.
    Massie BM
    Clin Cardiol; 1998 Dec; 21(12 Suppl 2):II12-7. PubMed ID: 9853194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Are all calcium antagonists alike?].
    Bertel O
    Schweiz Rundsch Med Prax; 1992 Feb; 81(7):164-7. PubMed ID: 1535950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium channel blockers for hypertension: dissecting the evidence for adverse effects.
    Opie LH
    Am J Hypertens; 1997 May; 10(5 Pt 1):565-77. PubMed ID: 9160770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse reactions with calcium antagonists.
    Krebs R
    Hypertension; 1983; 5(4 Pt 2):II125-9. PubMed ID: 6134672
    [No Abstract]   [Full Text] [Related]  

  • 14. [Side-effects of calcium inhibitors].
    Lavarenne J
    Therapie; 1989; 44(3):197-200. PubMed ID: 2675381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease.
    Murdoch D; Heel RC
    Drugs; 1991 Mar; 41(3):478-505. PubMed ID: 1711448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of patients with unstable angina or acute myocardial infarction treated with calcium channel antagonists.
    Ferrari R
    Am J Cardiol; 1996 Jun; 77(16):22D-25D. PubMed ID: 8677893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium antagonists in ischemic heart disease].
    Guize L
    J Mal Vasc; 1997 Oct; 22(4):222-8. PubMed ID: 9411006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity and intensity of adverse events in the treatment of hypertension with barnidipine.
    van der Velden JW; Beudeker HJ; Nishi M
    Blood Press Suppl; 1998; 1():27-9. PubMed ID: 9660524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of calcium antagonists under development.
    Abernethy DR; Schwartz JB
    Clin Pharmacokinet; 1988 Jul; 15(1):1-14. PubMed ID: 3042243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.